Article
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).
Atherosclerosis - 1 Mar 2018
Kayikcioglu Meral, Tokgozoglu Lale, Yilmaz Mehmet, Kaynar Leylagul, Aktan Melih, Durmuş Rana Berru, Gokce Cumali, Temizhan Ahmet, Ozcebe Osman Ilhami, Akyol Tulay Karaagac, Okutan Harika, Sag Saim, Gul Ozen Oz, Salcioglu Zafer, Yenercag Mustafa, Altunkeser Bulent B, Kuku Irfan, Yasar Hamiyet Yilmaz, Kurtoglu Erdal, Kose Melis Demir, Demircioglu Sinan, Pekkolay Zafer, Ilhan Osman
Abstract excerpt
BACKGROUND AND AIMS: Homozygous familial hypercholesterolemia (HoFH) is a genetic condition characterized by lethally high levels of low-density lipoprotein cholesterol (LDL-C) from birth, and requires rapid and aggressive intervention to prevent death due to coronary heart disease and/or atherosclerosis. Where available, lipoprotein apheresis (LA) is the mainstay of treatment to promote survival. METHODS: A-HIT1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
